The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Meglumine Diatrizoate Injection Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2029
Synopsis
The global Meglumine Diatrizoate Injection market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The major consumer markets for Meglumine Diatrizoate Injection are North America, Europe and the Asia-Pacific region. With the gradual recovery of the global economy after the COVID-19 outbreak and the return of major economies to normal, the medical industry will see certain growth. As the global medical level continues to improve, more and more hospitals and clinics are able to perform MRI and CT imaging. Therefore, the demand for Meglumine Diatrizoate Injection will increase in the foreseeable time.
Meglumine injection, indicated as this contrast agent for intravenous and retrograde urography; Cerebral, thoracic, abdominal and limbs angiography, venography and CT; It can also be used for arthrography, fistula imaging, hysterosalpingography, endoscopic retrograde cholangiopancreatography (ERCP), sialography, and other tests. Meglumine injection should not be used in selective coronary angiography. It should not be used for myelography, ventriculography, or cisternography as it may induce neurotoxic symptoms.
This report is a detailed and comprehensive analysis for global Meglumine Diatrizoate Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Meglumine Diatrizoate Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Bottles), and average selling prices (US$/Bottle), 2018-2029
Global Meglumine Diatrizoate Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Bottles), and average selling prices (US$/Bottle), 2018-2029
Global Meglumine Diatrizoate Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Bottles), and average selling prices (US$/Bottle), 2018-2029
Global Meglumine Diatrizoate Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Bottles), and ASP (US$/Bottle), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Meglumine Diatrizoate Injection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Meglumine Diatrizoate Injection market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AdvaCare Pharma, Shanghai Xudong Haipu Pharmaceutical, Hunan Hansen Pharmaceutical, Shanghai Bracco Sine Pharmaceutical and Lunan Pharmaceutical and etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Meglumine Diatrizoate Injection market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
1ml/0.3g
20ml/15.2g
20ml/12g
100ml/60g
Market segment by Application
Hospital
Clinic
Pharmacy
Major players covered
AdvaCare Pharma
Shanghai Xudong Haipu Pharmaceutical
Hunan Hansen Pharmaceutical
Shanghai Bracco Sine Pharmaceutical
Lunan Pharmaceutical
Xi'an Hanfeng Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Meglumine Diatrizoate Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Meglumine Diatrizoate Injection, with price, sales, revenue and global market share of Meglumine Diatrizoate Injection from 2018 to 2023.
Chapter 3, the Meglumine Diatrizoate Injection competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Meglumine Diatrizoate Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Meglumine Diatrizoate Injection market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Meglumine Diatrizoate Injection.
Chapter 14 and 15, to describe Meglumine Diatrizoate Injection sales channel, distributors, customers, research findings and conclusion.
The global Meglumine Diatrizoate Injection market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The major consumer markets for Meglumine Diatrizoate Injection are North America, Europe and the Asia-Pacific region. With the gradual recovery of the global economy after the COVID-19 outbreak and the return of major economies to normal, the medical industry will see certain growth. As the global medical level continues to improve, more and more hospitals and clinics are able to perform MRI and CT imaging. Therefore, the demand for Meglumine Diatrizoate Injection will increase in the foreseeable time.
Meglumine injection, indicated as this contrast agent for intravenous and retrograde urography; Cerebral, thoracic, abdominal and limbs angiography, venography and CT; It can also be used for arthrography, fistula imaging, hysterosalpingography, endoscopic retrograde cholangiopancreatography (ERCP), sialography, and other tests. Meglumine injection should not be used in selective coronary angiography. It should not be used for myelography, ventriculography, or cisternography as it may induce neurotoxic symptoms.
This report is a detailed and comprehensive analysis for global Meglumine Diatrizoate Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Meglumine Diatrizoate Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Bottles), and average selling prices (US$/Bottle), 2018-2029
Global Meglumine Diatrizoate Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Bottles), and average selling prices (US$/Bottle), 2018-2029
Global Meglumine Diatrizoate Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Bottles), and average selling prices (US$/Bottle), 2018-2029
Global Meglumine Diatrizoate Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Bottles), and ASP (US$/Bottle), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Meglumine Diatrizoate Injection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Meglumine Diatrizoate Injection market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AdvaCare Pharma, Shanghai Xudong Haipu Pharmaceutical, Hunan Hansen Pharmaceutical, Shanghai Bracco Sine Pharmaceutical and Lunan Pharmaceutical and etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Meglumine Diatrizoate Injection market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
1ml/0.3g
20ml/15.2g
20ml/12g
100ml/60g
Market segment by Application
Hospital
Clinic
Pharmacy
Major players covered
AdvaCare Pharma
Shanghai Xudong Haipu Pharmaceutical
Hunan Hansen Pharmaceutical
Shanghai Bracco Sine Pharmaceutical
Lunan Pharmaceutical
Xi'an Hanfeng Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Meglumine Diatrizoate Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Meglumine Diatrizoate Injection, with price, sales, revenue and global market share of Meglumine Diatrizoate Injection from 2018 to 2023.
Chapter 3, the Meglumine Diatrizoate Injection competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Meglumine Diatrizoate Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Meglumine Diatrizoate Injection market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Meglumine Diatrizoate Injection.
Chapter 14 and 15, to describe Meglumine Diatrizoate Injection sales channel, distributors, customers, research findings and conclusion.
Index1 Market Overview
1.1 Product Overview and Scope of Meglumine Diatrizoate Injection
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Meglumine Diatrizoate Injection Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 1ml/0.3g
1.3.3 20ml/15.2g
1.3.4 20ml/12g
1.3.5 100ml/60g
1.4 Market Analysis by Application
1.4.1 Overview: Global Meglumine Diatrizoate Injection Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Pharmacy
1.5 Global Meglumine Diatrizoate Injection Market Size & Forecast
1.5.1 Global Meglumine Diatrizoate Injection Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Meglumine Diatrizoate Injection Sales Quantity (2018-2029)
1.5.3 Global Meglumine Diatrizoate Injection Average Price (2018-2029)
2 Manufacturers Profiles
2.1 AdvaCare Pharma
2.1.1 AdvaCare Pharma Details
2.1.2 AdvaCare Pharma Major Business
2.1.3 AdvaCare Pharma Meglumine Diatrizoate Injection Product and Services
2.1.4 AdvaCare Pharma Meglumine Diatrizoate Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 AdvaCare Pharma Recent Developments/Updates
2.2 Shanghai Xudong Haipu Pharmaceutical
2.2.1 Shanghai Xudong Haipu Pharmaceutical Details
2.2.2 Shanghai Xudong Haipu Pharmaceutical Major Business
2.2.3 Shanghai Xudong Haipu Pharmaceutical Meglumine Diatrizoate Injection Product and Services
2.2.4 Shanghai Xudong Haipu Pharmaceutical Meglumine Diatrizoate Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Shanghai Xudong Haipu Pharmaceutical Recent Developments/Updates
2.3 Hunan Hansen Pharmaceutical
2.3.1 Hunan Hansen Pharmaceutical Details
2.3.2 Hunan Hansen Pharmaceutical Major Business
2.3.3 Hunan Hansen Pharmaceutical Meglumine Diatrizoate Injection Product and Services
2.3.4 Hunan Hansen Pharmaceutical Meglumine Diatrizoate Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Hunan Hansen Pharmaceutical Recent Developments/Updates
2.4 Shanghai Bracco Sine Pharmaceutical
2.4.1 Shanghai Bracco Sine Pharmaceutical Details
2.4.2 Shanghai Bracco Sine Pharmaceutical Major Business
2.4.3 Shanghai Bracco Sine Pharmaceutical Meglumine Diatrizoate Injection Product and Services
2.4.4 Shanghai Bracco Sine Pharmaceutical Meglumine Diatrizoate Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Shanghai Bracco Sine Pharmaceutical Recent Developments/Updates
2.5 Lunan Pharmaceutical
2.5.1 Lunan Pharmaceutical Details
2.5.2 Lunan Pharmaceutical Major Business
2.5.3 Lunan Pharmaceutical Meglumine Diatrizoate Injection Product and Services
2.5.4 Lunan Pharmaceutical Meglumine Diatrizoate Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Lunan Pharmaceutical Recent Developments/Updates
2.6 Xi'an Hanfeng Pharmaceutical
2.6.1 Xi'an Hanfeng Pharmaceutical Details
2.6.2 Xi'an Hanfeng Pharmaceutical Major Business
2.6.3 Xi'an Hanfeng Pharmaceutical Meglumine Diatrizoate Injection Product and Services
2.6.4 Xi'an Hanfeng Pharmaceutical Meglumine Diatrizoate Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Xi'an Hanfeng Pharmaceutical Recent Developments/Updates
3 Competitive Environment: Meglumine Diatrizoate Injection by Manufacturer
3.1 Global Meglumine Diatrizoate Injection Sales Quantity by Manufacturer (2018-2023)
3.2 Global Meglumine Diatrizoate Injection Revenue by Manufacturer (2018-2023)
3.3 Global Meglumine Diatrizoate Injection Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Meglumine Diatrizoate Injection by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Meglumine Diatrizoate Injection Manufacturer Market Share in 2022
3.4.2 Top 6 Meglumine Diatrizoate Injection Manufacturer Market Share in 2022
3.5 Meglumine Diatrizoate Injection Market: Overall Company Footprint Analysis
3.5.1 Meglumine Diatrizoate Injection Market: Region Footprint
3.5.2 Meglumine Diatrizoate Injection Market: Company Product Type Footprint
3.5.3 Meglumine Diatrizoate Injection Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Meglumine Diatrizoate Injection Market Size by Region
4.1.1 Global Meglumine Diatrizoate Injection Sales Quantity by Region (2018-2029)
4.1.2 Global Meglumine Diatrizoate Injection Consumption Value by Region (2018-2029)
4.1.3 Global Meglumine Diatrizoate Injection Average Price by Region (2018-2029)
4.2 North America Meglumine Diatrizoate Injection Consumption Value (2018-2029)
4.3 Europe Meglumine Diatrizoate Injection Consumption Value (2018-2029)
4.4 Asia-Pacific Meglumine Diatrizoate Injection Consumption Value (2018-2029)
4.5 South America Meglumine Diatrizoate Injection Consumption Value (2018-2029)
4.6 Middle East and Africa Meglumine Diatrizoate Injection Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Meglumine Diatrizoate Injection Sales Quantity by Type (2018-2029)
5.2 Global Meglumine Diatrizoate Injection Consumption Value by Type (2018-2029)
5.3 Global Meglumine Diatrizoate Injection Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Meglumine Diatrizoate Injection Sales Quantity by Application (2018-2029)
6.2 Global Meglumine Diatrizoate Injection Consumption Value by Application (2018-2029)
6.3 Global Meglumine Diatrizoate Injection Average Price by Application (2018-2029)
7 North America
7.1 North America Meglumine Diatrizoate Injection Sales Quantity by Type (2018-2029)
7.2 North America Meglumine Diatrizoate Injection Sales Quantity by Application (2018-2029)
7.3 North America Meglumine Diatrizoate Injection Market Size by Country
7.3.1 North America Meglumine Diatrizoate Injection Sales Quantity by Country (2018-2029)
7.3.2 North America Meglumine Diatrizoate Injection Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Meglumine Diatrizoate Injection Sales Quantity by Type (2018-2029)
8.2 Europe Meglumine Diatrizoate Injection Sales Quantity by Application (2018-2029)
8.3 Europe Meglumine Diatrizoate Injection Market Size by Country
8.3.1 Europe Meglumine Diatrizoate Injection Sales Quantity by Country (2018-2029)
8.3.2 Europe Meglumine Diatrizoate Injection Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Meglumine Diatrizoate Injection Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Meglumine Diatrizoate Injection Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Meglumine Diatrizoate Injection Market Size by Region
9.3.1 Asia-Pacific Meglumine Diatrizoate Injection Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Meglumine Diatrizoate Injection Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Meglumine Diatrizoate Injection Sales Quantity by Type (2018-2029)
10.2 South America Meglumine Diatrizoate Injection Sales Quantity by Application (2018-2029)
10.3 South America Meglumine Diatrizoate Injection Market Size by Country
10.3.1 South America Meglumine Diatrizoate Injection Sales Quantity by Country (2018-2029)
10.3.2 South America Meglumine Diatrizoate Injection Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Meglumine Diatrizoate Injection Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Meglumine Diatrizoate Injection Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Meglumine Diatrizoate Injection Market Size by Country
11.3.1 Middle East & Africa Meglumine Diatrizoate Injection Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Meglumine Diatrizoate Injection Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Meglumine Diatrizoate Injection Market Drivers
12.2 Meglumine Diatrizoate Injection Market Restraints
12.3 Meglumine Diatrizoate Injection Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Meglumine Diatrizoate Injection and Key Manufacturers
13.2 Manufacturing Costs Percentage of Meglumine Diatrizoate Injection
13.3 Meglumine Diatrizoate Injection Production Process
13.4 Meglumine Diatrizoate Injection Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Meglumine Diatrizoate Injection Typical Distributors
14.3 Meglumine Diatrizoate Injection Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
